JPRN-UMIN000047191招募中未知
Management and Treatment for Radiation-Induced Colitis - MATRICS
ational Institutes for Quantum Science and Technology0 个研究点目标入组 6 人开始时间: 2022年3月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who are considered to be unable to undergo the prescribed hospital visits and examinations. 2) Patients who are receiving chemotherapy or who have not completed chemotherapy within 2 weeks of the start of irradiation. 3) Patients with open wounds or active, refractory infections in the irradiated area. 4) Patients have active multiple cancers. 5) Patients with serious complications. 6) Patients with mental illness or psychiatric symptoms that would make participation in the clinical research difficult or adults who are incapable of consenting. (7) Patients who are considered to be unsuitable for enrollment in this study by the physician.
研究者
相似试验
已完成
不适用
The effective management of radiation-induced bowel injury: a randomised controlled trialISRCTN22890916Record Provided by the NHSTCT Register - 2007 Update - Department of Health218
招募中
不适用
Treatment of radiation dermatitishead and neck cancerJPRN-UMIN000017741Kumamoto University Graduate School of Medicine90
招募中
3 期
Postoperative radiotherapy (PORT) for pathological N2 non-small cell lung cancer with adjuvant chemotherapy: a randomized phase III trial (JCOG1916, J-PORT)pathological N2 non-small cell lung cancerJPRN-UMIN000042905Japan Clinical Oncology Group (JCOG)330
招募中
1 期
Clinical study on prevention and treatment of radiation acute oral mucositis in patients with nasopharyngeal carcinoma by self-prepared Chinese herbal compound preparatioITMCTR2100004944Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
已完成
2 期
Phase II study of radiation therapy for isolated para-aoritc lymph node recurrence in patients with uterine cervical carcinomauterine cervical carcinomaJPRN-UMIN000000904Kitasato Gynecologic Radiation Oncology Group: KGROG22